Green, unexpected synthesis of bis-coumarin derivatives as potent anti-bacterial and anti-inflammatory agents. 2018

Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
Department of Chemistry, Karnatak University, Dharwad, 580 003, Karnataka, India.

A green and efficient protocol has been developed and a series of coumarin based pyrano[3,2-c]chromene derivatives (2) have been synthesized using multi-component reaction (MCR) approach. Unexpected 3-coumarinyl-3-pyrazolylpropanoic acids (3) and C4-C4 chromenes (5) have been isolated instead of expected product 4 by the reaction of compound (2) in formic acid at 90 °C for about 4-5 h and at 130 °C for about 8-10 h respectively. Further, C4-C4chromenes (5) formation was confirmed by intramolecular cyclization of compounds (3). These compounds were screened for their biological activities and most of them exhibited promising antibacterial activity. The anti-inflammatory assay was evaluated against HRBC membrane stabilization method and the compounds exhibit excellent anti-inflammatory activity. Molecular docking study has been performed for all the synthesized compounds with Klebsiella pneumoni aeacetolactate synthase and results obtained are quite promising.

UI MeSH Term Description Entries
D008297 Male Males
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
January 2017, Anti-cancer agents in medicinal chemistry,
Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
May 2020, Chemical & pharmaceutical bulletin,
Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
January 2022, Mini reviews in medicinal chemistry,
Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
June 2023, International journal of molecular sciences,
Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
December 2014, Bioorganic & medicinal chemistry letters,
Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
July 2020, Molecules (Basel, Switzerland),
Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
June 2020, Molecules (Basel, Switzerland),
Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
January 2005, Medicina (Kaunas, Lithuania),
Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
June 2015, Bioorganic & medicinal chemistry letters,
Bahubali M Chougala, and S Samundeeswari, and Megharaja Holiyachi, and Nirmala S Naik, and Lokesh A Shastri, and Suneel Dodamani, and Sunil Jalalpure, and Sheshagiri R Dixit, and Shrinivas D Joshi, and Vinay A Sunagar
January 2024, Natural product research,
Copied contents to your clipboard!